Yakira Capital Management’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-34,538
| Closed | -$76.3K | – | 285 |
|
|
2024
Q1 | $76.3K | Buy |
+34,538
| New | +$76.3K | 0.02% | 134 |
|
|
2023
Q2 | – | Sell |
-90,076
| Closed | -$147K | – | 375 |
|
|
2023
Q1 | $147K | Hold |
90,076
| – | – | 0.04% | 156 |
|
|
2022
Q4 | $120K | Hold |
90,076
| – | – | 0.02% | 182 |
|
|
2022
Q3 | $141K | Hold |
90,076
| – | – | 0.02% | 249 |
|
|
2022
Q2 | $139K | Sell |
90,076
-27,000
| -23% | -$41.7K | 0.02% | 254 |
|
|
2022
Q1 | $300K | Buy |
+117,076
| New | +$300K | 0.04% | 268 |
|